The Impact of Healthcare Reform in M&A
Overview:
Our panel of key thought leaders and practitioners assembled by The Knowledge Group will offer a discussion on the fundamentals and updates regarding the latest and significant issues surrounding the Impact of Healthcare Reform in M&A. This LIVE Webcast aims to help you avoid common pitfalls and risk issues in connection with this current topic on healthcare.
Some of the Major Topics that will be covered in this course are:
- Brief Introduction
- Brief background describing shift from fee for service environment to value based care model as a result of healthcare reform
- Observations on M&A trends within healthcare in wake of the enactment of healthcare reform in 2010 to present, including:
- Provider consolidation for scale
- Vertical integration within provider space
- Payer consolidation and acquisitions of technology & service platforms
- Cross sector convergence
- Life sciences M&A trends
- Capital markets role in Healthcare M&A
- Acquisition Strategies
- M&A Process – Due Diligence, Structure and Integration
- Technology – Drivers and role under Healthcare Reform
- Observations on 2014 M&A trends in healthcare & life sciences
- Potential challenges and opportunities stemming from healthcare reform that may shape deal activity going forward
Agenda:
John V. Pellitteri, Partner Healthcare Management Consulting Practice Leader Accounting Services Practice Leader
Grassi & Co.
- Introductory segment
David McMillan, Principal
Pershing Yoakley & Associates, P.C.
An Alternative To Traditional M&A: Hospital Network Alliances
- Common characteristics:
- Two or more hospitals enter into a formal relationship to share resources and capabilities with an eye toward clinical integration
- Participants together define their common interests to be advanced through the alliance
- Each participant’s individual interests are respected and protected through the alliance’s governance structure
- Participants make some financial commitment to support the alliance’s operations, but each remains economically independent
- Key considerations:
- Motivations for pursuing relationships
- How Network Alliances are formed and governed
- Scope of their partners’ relationship
- Secrets to success and dangers to avoid
Dan Probst, Senior Manager – Life Sciences and Healthcare M&A Transaction Services
Deloitte
and
John V. Pellitteri, Partner Healthcare Management Consulting Practice Leader Accounting Services Practice Leader
Grassi & Co.
- DAN: Brief background describing shift from fee for service environment to value based care model as a result of healthcare reform
- DAN: Observations on M&A trends within healthcare in wake of the enactment of healthcare reform in 2010 to present, including:
- DAN: Provider consolidation for scale
- DAN: Vertical integration within provider space
- DAN: Payer consolidation and acquisitions of technology & service platforms
- DAN: Cross sector convergence
- DAN: Life sciences M&A trends
- JOHN: Capital markets role in Healthcare M&A
- JOHN: Acquisition Strategies
- JOHN : M&A Process – Due Diligence, Structure and Integration
- JOHN: Technology – Drivers and role under Healthcare Reform
- DAN: Observations on 2014 M&A trends in healthcare & life sciences
- DAN Potential challenges and opportunities stemming from healthcare reform that may shape deal activity going forward
Who Should Attend:
- M&A Experts
- Hospital Directors
- Health Care Law Attorneys
- Attorneys/Consultants in Healthcare Practice
- CEOs
- Compliance Officers
- Medical Directors
- Medical Providers - Office Nurses
- Risk Managers
- Medical Management Supervisors
- Senior Corporate Management
- Health Care Advisory Services Consultants
- Health Policy Directors
- State Health Executives
- Human Resource & Benefits Personnel
- And Other Interested/Related Professionals
John Pellitteri, CPA is a Partner at Grassi and Co. , CPA’S and leads the firms Healthcare Industry Practice. He …
David McMillan is a Principal in the healthcare consulting group of Pershing Yoakley & Associate, P.C. and leads strategic planning …
Dan’s clients include a number of private equity funds and strategic buyers. He has significant experience assisting clients with financial …
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-demand Webcast
Prerequisite:
NONE
Course Code:
134587
NASBA Field of Study:
Specialized Knowledge and Applications
NY Category of CLE Credit:
Skills
Total Credits:
2.0 CLE
2.0 CPE
Login Instructions:
No Access
You are not logged in. Please Login or register to the event to gain access to the materials and login instructions.
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
SPEAKERS' FIRMS:
About Pershing Yoakley & Associates, P.C.
Ranked by Modern Healthcare as the nation’s 10th largest privately held healthcare consulting firm, PYA serves clients in 48 states from offices in Atlanta, Kansas City, Knoxville, Nashville, and Tampa Bay. PYA and its affiliate companies - Realty Trust Group, PYA Waltman Capital, Healthcare Horizons Consulting Group, and PYA Analytics - have more than 270 employees.
Website: https://www.pyapc.com/
About Deloitte
Deloitte’s Merger & Acquisition Services
Deloitte’s Merger and Acquisition services advise corporate buyers and private equity investors throughout the entire M&A deal lifecycle. From strategy development and target screening through transaction execution, integration, and even divestiture, our M&A professionals have the domain knowledge, extensive industry expertise and global reach to provide a tailored approach designed to address unique needs and help build value for clients. To learn more about M&A services across the deal lifecycle, visit: www.deloitte.com/us/ma.
Website: https://www.deloitte.com
Related Webcasts:
HIPAA Security Rule and Security Risk Management: Addressing Threats and Vulnerabilities During the Pandemic
12:00pm to 2:00pm
Revenue Cycle Management in the Healthcare Industry: Exploring Potentials and Pitfalls
3:00pm to 5:00pm
Demystifying the Drug Pricing Landscape: Trends, Developments, and Risk Issues Explored
3:00pm to 5:00pm